Effects of pre-operative administration of medetomidine on plasma insulin and glucose concentrations in healthy dogs and dogs with insulinoma

Alonso Gp Guedes, Elaine P. Rude

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Objective: To investigate the effect of medetomidine on plasma glucose and insulin concentrations in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery. Animals: Twenty-five dogs with insulinoma and 26 healthy dogs. Methods: In dogs with insulinoma, medetomidine (5 μg kg-1) was randomly included (n = 12) or omitted (n = 13) from the pre-anesthetic medication protocol, which typically contained an opioid and an anticholinergic. Healthy dogs received medetomidine (5 μg kg-1; n = 13) or acepromazine (0.04 mg kg-1; n = 13) plus an opioid (morphine 0.5 mg kg-1) and an anticholinergic (atropine 0.04 mg kg-1) as pre-anesthetic medications. Pre-anesthetic medications were given intramuscularly. Plasma glucose and insulin concentrations were measured before (sample 1) and 30 minutes after pre-anesthetic medication (sample 2), and at the end of surgery in dogs with insulinoma or at 2 hours of anesthesia in healthy dogs (sample 3). Glucose requirement to maintain intra-operative normoglycemia in dogs with insulinoma was quantified and compared. Data were analyzed with anova and Bonferroni post-test, t-tests or chi-square tests as appropriate with p < 0.05 considered significant. Data are shown as mean ± SD. Results: Medetomidine significantly decreased plasma insulin concentrations and increased plasma glucose concentrations in healthy dogs and those with insulinoma. These variables did not change significantly in the dogs not receiving medetomidine. In the dogs with insulinoma, intra-operative glucose administration rate was significantly less in the animals that received medetomidine compared to those that did not. Conclusions: Pre-anesthetic administration of medetomidine significantly suppressed insulin secretion and increased plasma glucose concentration in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery. Clinical relevance: These findings support the judicious use of medetomidine at low doses as an adjunct to the anesthetic management of dogs with insulinoma.

Original languageEnglish (US)
Pages (from-to)472-481
Number of pages10
JournalVeterinary Anaesthesia and Analgesia
Volume40
Issue number5
DOIs
StatePublished - Sep 2013
Externally publishedYes

Fingerprint

Medetomidine
Insulinoma
medetomidine
insulin
Dogs
Insulin
Glucose
glucose
dogs
preanesthetic medication
Anesthetics
anesthesia
Anesthesia
surgery
narcotics
Cholinergic Antagonists
anesthetics
Opioid Analgesics
Acepromazine
acepromazine

Keywords

  • Alpha-2 agonists
  • Dogs
  • Glucose
  • Insulin
  • Insulinoma
  • Medetomidine

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Effects of pre-operative administration of medetomidine on plasma insulin and glucose concentrations in healthy dogs and dogs with insulinoma. / Guedes, Alonso Gp; Rude, Elaine P.

In: Veterinary Anaesthesia and Analgesia, Vol. 40, No. 5, 09.2013, p. 472-481.

Research output: Contribution to journalArticle

@article{ad2f9dd54f1b4d44a33f06f9be54f671,
title = "Effects of pre-operative administration of medetomidine on plasma insulin and glucose concentrations in healthy dogs and dogs with insulinoma",
abstract = "Objective: To investigate the effect of medetomidine on plasma glucose and insulin concentrations in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery. Animals: Twenty-five dogs with insulinoma and 26 healthy dogs. Methods: In dogs with insulinoma, medetomidine (5 μg kg-1) was randomly included (n = 12) or omitted (n = 13) from the pre-anesthetic medication protocol, which typically contained an opioid and an anticholinergic. Healthy dogs received medetomidine (5 μg kg-1; n = 13) or acepromazine (0.04 mg kg-1; n = 13) plus an opioid (morphine 0.5 mg kg-1) and an anticholinergic (atropine 0.04 mg kg-1) as pre-anesthetic medications. Pre-anesthetic medications were given intramuscularly. Plasma glucose and insulin concentrations were measured before (sample 1) and 30 minutes after pre-anesthetic medication (sample 2), and at the end of surgery in dogs with insulinoma or at 2 hours of anesthesia in healthy dogs (sample 3). Glucose requirement to maintain intra-operative normoglycemia in dogs with insulinoma was quantified and compared. Data were analyzed with anova and Bonferroni post-test, t-tests or chi-square tests as appropriate with p < 0.05 considered significant. Data are shown as mean ± SD. Results: Medetomidine significantly decreased plasma insulin concentrations and increased plasma glucose concentrations in healthy dogs and those with insulinoma. These variables did not change significantly in the dogs not receiving medetomidine. In the dogs with insulinoma, intra-operative glucose administration rate was significantly less in the animals that received medetomidine compared to those that did not. Conclusions: Pre-anesthetic administration of medetomidine significantly suppressed insulin secretion and increased plasma glucose concentration in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery. Clinical relevance: These findings support the judicious use of medetomidine at low doses as an adjunct to the anesthetic management of dogs with insulinoma.",
keywords = "Alpha-2 agonists, Dogs, Glucose, Insulin, Insulinoma, Medetomidine",
author = "Guedes, {Alonso Gp} and Rude, {Elaine P.}",
year = "2013",
month = "9",
doi = "10.1111/vaa.12047",
language = "English (US)",
volume = "40",
pages = "472--481",
journal = "Veterinary Anaesthesia and Analgesia",
issn = "1467-2987",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Effects of pre-operative administration of medetomidine on plasma insulin and glucose concentrations in healthy dogs and dogs with insulinoma

AU - Guedes, Alonso Gp

AU - Rude, Elaine P.

PY - 2013/9

Y1 - 2013/9

N2 - Objective: To investigate the effect of medetomidine on plasma glucose and insulin concentrations in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery. Animals: Twenty-five dogs with insulinoma and 26 healthy dogs. Methods: In dogs with insulinoma, medetomidine (5 μg kg-1) was randomly included (n = 12) or omitted (n = 13) from the pre-anesthetic medication protocol, which typically contained an opioid and an anticholinergic. Healthy dogs received medetomidine (5 μg kg-1; n = 13) or acepromazine (0.04 mg kg-1; n = 13) plus an opioid (morphine 0.5 mg kg-1) and an anticholinergic (atropine 0.04 mg kg-1) as pre-anesthetic medications. Pre-anesthetic medications were given intramuscularly. Plasma glucose and insulin concentrations were measured before (sample 1) and 30 minutes after pre-anesthetic medication (sample 2), and at the end of surgery in dogs with insulinoma or at 2 hours of anesthesia in healthy dogs (sample 3). Glucose requirement to maintain intra-operative normoglycemia in dogs with insulinoma was quantified and compared. Data were analyzed with anova and Bonferroni post-test, t-tests or chi-square tests as appropriate with p < 0.05 considered significant. Data are shown as mean ± SD. Results: Medetomidine significantly decreased plasma insulin concentrations and increased plasma glucose concentrations in healthy dogs and those with insulinoma. These variables did not change significantly in the dogs not receiving medetomidine. In the dogs with insulinoma, intra-operative glucose administration rate was significantly less in the animals that received medetomidine compared to those that did not. Conclusions: Pre-anesthetic administration of medetomidine significantly suppressed insulin secretion and increased plasma glucose concentration in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery. Clinical relevance: These findings support the judicious use of medetomidine at low doses as an adjunct to the anesthetic management of dogs with insulinoma.

AB - Objective: To investigate the effect of medetomidine on plasma glucose and insulin concentrations in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery. Animals: Twenty-five dogs with insulinoma and 26 healthy dogs. Methods: In dogs with insulinoma, medetomidine (5 μg kg-1) was randomly included (n = 12) or omitted (n = 13) from the pre-anesthetic medication protocol, which typically contained an opioid and an anticholinergic. Healthy dogs received medetomidine (5 μg kg-1; n = 13) or acepromazine (0.04 mg kg-1; n = 13) plus an opioid (morphine 0.5 mg kg-1) and an anticholinergic (atropine 0.04 mg kg-1) as pre-anesthetic medications. Pre-anesthetic medications were given intramuscularly. Plasma glucose and insulin concentrations were measured before (sample 1) and 30 minutes after pre-anesthetic medication (sample 2), and at the end of surgery in dogs with insulinoma or at 2 hours of anesthesia in healthy dogs (sample 3). Glucose requirement to maintain intra-operative normoglycemia in dogs with insulinoma was quantified and compared. Data were analyzed with anova and Bonferroni post-test, t-tests or chi-square tests as appropriate with p < 0.05 considered significant. Data are shown as mean ± SD. Results: Medetomidine significantly decreased plasma insulin concentrations and increased plasma glucose concentrations in healthy dogs and those with insulinoma. These variables did not change significantly in the dogs not receiving medetomidine. In the dogs with insulinoma, intra-operative glucose administration rate was significantly less in the animals that received medetomidine compared to those that did not. Conclusions: Pre-anesthetic administration of medetomidine significantly suppressed insulin secretion and increased plasma glucose concentration in dogs with insulinoma and in healthy dogs undergoing anesthesia and surgery. Clinical relevance: These findings support the judicious use of medetomidine at low doses as an adjunct to the anesthetic management of dogs with insulinoma.

KW - Alpha-2 agonists

KW - Dogs

KW - Glucose

KW - Insulin

KW - Insulinoma

KW - Medetomidine

UR - http://www.scopus.com/inward/record.url?scp=84881557750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84881557750&partnerID=8YFLogxK

U2 - 10.1111/vaa.12047

DO - 10.1111/vaa.12047

M3 - Article

C2 - 23714015

AN - SCOPUS:84881557750

VL - 40

SP - 472

EP - 481

JO - Veterinary Anaesthesia and Analgesia

JF - Veterinary Anaesthesia and Analgesia

SN - 1467-2987

IS - 5

ER -